Anal High Grade Squamous Intraepithelial Lesion clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
San Francisco, California and other locations
Our lead scientists for Anal High Grade Squamous Intraepithelial Lesion research studies include Joel Palefsky, MD.